• Home
  • Victims
    • Vaccine Victims Memorial
    • Gardasil & Silgard
      • G / S Australasia
        • G / S Australia
        • G / S New Zealand
      • G / S Europe
        • G / S Czech Republic
        • G / S Denmark
        • G / S France
        • G / S Germany
        • G / S Ireland
        • G / S Italy
        • G / S Norway
        • G / S Scotland
        • G / S Spain
        • G / S United Kingdom
      • G / S N. America
        • G / S Canada
        • G / S Mexico
        • G / S United States
      • G / S S. America
        • G / S Brazil
        • G/S Colombia
    • Cervarix
      • Cervarix Asia
        • Cervarix India
        • Cervarix Philippines
      • Cervarix Europe
        • Cervarix Czech
        • Cervarix Netherlands
        • Cervarix Scotland
        • Cervarix Slovakia
        • Cervarix Spain
        • Cervarix UK
      • Cervarix N. America
        • Cervarix Mexico
  • Resources
    • HPV Testing Resources
      • Pre-HPV Vaccination
      • Post-HPV Vaccination
    • Medical Professionals
    • Vaccine Injury Attorneys
    • Political Action Groups
    • Vaccine Groups
    • Vaccine Victims Hotline
  • SANE Vax Press Releases
  • Videos
    • Vaccine Safety Videos
    • Vaccine Victim Videos
    • Pharma Videos
  • About
    • About Us
    • Who We Are
    • Press Releases
    • SANE Vax in the News
    • Contact Us

SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

  • NEWS
    • Government Agencies
      • African
      • Asian
      • Australasian
      • European
      • North American
      • South American
      • United Nations
      • WHO
    • Pharmaceutical Companies
      • CSL Biotherapies
      • GlaxoSmithKline
      • Inovio Pharmaceuticals
      • Liquidia Technologies
      • Merck & Co.
      • Novartis
      • Pfizer
      • Qiagen
      • Sanofi Aventis
      • Sanofi Pasteur MSD spmsd
      • Wyeth Laboratories
    • Science & Medicine
      • Cancer
      • Clinical Trials
      • Environmental Health
      • Heavy Metal Toxicity
      • HPV Science
      • Influenza
      • Meningitis
      • Pertussis
      • Pharmaceuticals
      • Rotavirus
      • STD’s
      • Vaccine Science
      • Women’s Health
    • Vaccine Adverse Events
    • Vaccine Injury Reporting
      • VAERS
      • VAMPSS
    • Vaccine Litigation
    • Vaccine Marketing
    • Vaccine Politics/People
    • Vaccine Victims
      • Cervarix Injuries
      • DTP/DTaP Injuries
      • Fluvax Injuries
      • Fluzone Injuries
      • Gardasil / Silgard Injuries
      • Menomune Injuries
      • MMR Injuries
      • Polio Vaccine Injuries
      • Synflorix Injuries
      • Yellow Fever Vaccine
    • Vaccines
      • Anthrax
      • Breast Cancer
      • Chicken Pox
      • Cholera
      • Combination Vaccines
      • Diphtheria
      • Hepatitis B
      • HPV
      • Influenza Vaccines
      • Malaria
      • Measles
      • Meningitis Vaccines
      • MRSA
      • Mumps
      • Norovirus
      • Pertussis Vaccines
      • Pneumococcal Disease
      • Polio
      • Rotavirus Vaccines
      • Shingles
      • Smallpox
      • TB
      • Tetanus
      • Typhoid
      • Yellow Fever Vaccine
    • Vaccines and the Media
  • WORLD NEWS
    • Africa
    • Asia
    • Australasia
    • Europe
    • North America
    • South America
  • RESEARCH
    • Cancer Research
    • Cervarix Vaccine
    • Gardasil/Silgard Vaccine
    • Human Pap. Research
    • Immunization Practices
    • Neurology
    • Vaccine Adjuvants
    • Vac. Ingredient Research
    • Vaccine Injuries
    • Vaccine Preservatives
    • Vaccine Related Research
    • Vaccine Safety
  • CITIZENS SPEAK
    • Cervical Cancer Debate
    • HPV Vax
      • Australian Concerns
      • Canadian Concerns
      • Irish Concerns
      • Spain Concerns
      • UK Concerns
      • United States Concerns
You are here: Home / NEWS . . . . . . . . / Science & Medicine / Clinical Trials / HPV Vaccine Trials in India: Is Merck above the law?

HPV Vaccine Trials in India: Is Merck above the law?

July 7, 2014 By Norma 15 Comments

SaneVax-FeaturedBy Norma Erickson

3 July 2014: As a result of continued investigations regarding clinical trials involving HPV vaccines in India, more allegations of unethical conduct have been lodged against Merck. These allegations pertain to Merck’s recent trials of the new V503 HPV vaccine, a proposed nine valent HPV vaccine. A complete report of the investigation results written by Dr. Anand Rai, Kelly O’Connor, Amoli Tuli, and Anisha Bhattacharya is now a matter of public record.

The additional allegations of multiple ethics violations were added to a currently ongoing Supreme Court Case via an affidavit added as an addendum to the brief previously prepared regarding the ’demonstration projects’ conducted by a U.S NGO PATH in India beginning in 2009. The deaths of subjects during the ’demonstration projects’ resulted in a government-ordered enquiry and  suspension of all HPV vaccine trials in India pending further investigation. This suspension was effective as of April 2010 and is still in effect.

Ultimately, the suspension and subsequent investigations allowed advocates in India to take their case all the way to the Supreme Court. The petition for the case was formally admitted by the judges on January 7, 2013. By September 2013, the court had issued notices to all participants involved while the Indian Parliament issued a scathing comment condemning all organizations involved in the so-called ’demonstration projects’ calling them a case of child abuse expressly carried out to create a market for the two companies – Merck and GlaxoSmithKline.

According to new allegations, Merck ignored the suspension of HPV-related clinical trials and continued with a phase III trial of the yet-to-be-approved investigational HPV vaccine called V503, which theoretically adds protection against 5 types of HPV to the ones already included in their current HPV vaccine, Gardasil.

Allegations of Merck’s Misconduct

The supplemental affidavit submitted to the Supreme Court of India states that Merck and/or their representatives committed the following violations of basic human rights:

1. Respondent No. 8, MSD Pharmaceuticals Pvt. Ltd.  and its affiliate companies in respect of pre-licensure trials with investigational HPV vaccine V-503.

2. Pre-licensure Phase III trials were carried out at many centres in India. One of these centres was Indore. In Indore this vaccine was administered to 44 children, boys and girls. A field study with the participants was carried out by Dr. Anand Rai and others and is detailed in the Annexure.

3. The timing of this trial was such that vaccination was carried out during the same period when Respondent no. 1, The Ministry of Health and Family Welfare, had asked all HPV related studies to suspend vaccination. As such then this was a violation of the government orders.

4. The Annexure also lists in detail all the problems with this trial on a case by case basis, some of them are summarized below:

a) This clinical trial was not preceded by any trial among adults thereby violating the Drugs and Cosmetics Act. This trial had the approval of the Respondent No. 2, The Drugs Controller General of India (DCGI), who violated the law that his job specifically asked him to uphold. The petitioners have complained to the court that is the second time regarding HPV vaccines the DCGI bestowed this favour on Merck and its associates.

b) The trial used middle men and women acting as agents of the investigator who went around residential areas recruiting subjects in complete violation of all national and international guidelines.

c) The trial was carried out at a government hospital using government stationery and seal even though this was a privately sponsored trial of the company thereby misusing the trust parents place in the governmental vaccination programmes.

d) The parents and children were told that they were getting a successful vaccine from abroad free which would otherwise cost Rs 10,000. This was a blatant lie as this vaccine was not approved for marketing anywhere in the world. Also this constituted undue inducement to recruit children to this trial.

e) None of the participants were informed that they were participating in a clinical trial.

f) Economically vulnerable sections and those from scheduled castes and minorities were recruited for the trial, those who would not be able to afford the vaccine if and when it is marketed; thereby the trial further violated all laws and guidelines in this regard.

g) Merck listed history of allergic reaction that required medical intervention, currently enrolled in another clinical trial, subject is pregnant, subject is immunocompromised or has taken immunosuppressants in the last year, subject has received a marketed HPV vaccine or participated in an HPV vaccine clinical trial and subject has history of positive test for HPV as exclusion criteria for this clinical trial. No examinations of the children who were selected for participation were undertaken prior to administration of the V503 vaccine.

h) There was no placebo involved in this trial, simply three different lots of V503, despite the fact that one purpose of the trials was to detect potential safety issues.

i) From the beginning to end, there was no examination of the children for their health status, and even though the trial was supposedly carried out to determine the safety of the vaccine not even fever post vaccination was recorded.

j) No medical care was provided for the health problems of the children nor were they provided any compensation. The study found many children who continue to suffer new medical problems even as late as 2013. Out of the 12 individuals interviewed, 4 have experienced health problems after the vaccine, such as mood swings, persistent stomach aches, dizziness, late onset of periods and severe anaemia. One boy whose family was interviewed has suffered extreme weight loss.

k) Though the investigation covered only the trial centre at Indore the entire list of trial centres is placed in the supplemental affidavit for information. In all hundreds of children have been affected in India.

One would think all of the complaints filed against PATH and Merck during the ’demonstration projects’ for Gardasil would have caused them to be on their best behavior. But apparently, when the government officials in India called a halt to any trials relating to HPV, Merck thought the decree did not apply to them. Either that, or they believed themselves powerful enough to be above the law.

Whatever the motivation, it appears hundreds more economically disadvantaged children and their families were put at risk by their participation in a clinical trial they were not told they were taking part in.

Compound this disregard for informed consent with participants being told they were priviledged to receive a successful and very expensive vaccine from overseas. Nevermind the fact that this ’successful vaccine’ had not been approved for use in any country in the world.

The people of India are not the only ones who may suffer the effects of this particular set of clinical trials. What ’results’ will Merck report to the rest of the world on this set of trials where the exclusion criteria was apparently ignored?

What ’results’ will Merck report to the rest of the world when no adverse events were recorded? One can certainly assume the adverse events which apparently were not recorded will no longer exist.

Will pretending these new medical conditions did not happen allow Merck to report their new V503 HPV vaccine is safe?

Is Merck above the law?

Will Merck be allowed to ignore the international laws protecting the basic right of informed consent prior to participation in clinical trials? Will Merck be allowed to continue to exploit economically disadvantaged people then extrapolate the resulting ’conclusions’ to the entire population of the world?

One can only hope the Supreme Court in India decides to protect the health and well-being of their young people by responding to the complaints of the organizations who put forth the allegations in a manner which will stop these types of abuses from ever happening in their country again.

By doing so, India’s Supreme Court Judges could help protect all of the world’s young people.

The Supreme Court of India has scheduled the final hearing of this case for August 12, 2014. The Court’s decision should be rendered on that date.

Whatever the ultimate outcome, advocates around the world will be watching.

Read this article in French here.


 

Related

Filed Under: Clinical Trials, India, Merck & Co., SANE Vax Press Releases, Vaccine Litigation Tagged With: clinical trials, Merck, unethical conduct, V503 trials

Comments

  1. Sandy says

    July 7, 2014 at 11:27 am

    Tragically, India may be added to the growing list of countries where countless inhabitants are suffering permanently damaged health and even deaths caused by HPV vaccines.

    There are many grave concerns about this new HPV vaccine including:

    – The culture of corruption and indeed criminality which is once again exhibited by Merck.
    – Damaged health and deaths of many poor victims of the unethical trials.
    – Manipulated trials where reactions were only registered for a short period of time, when autoimmune conditions may appear up to years after vaccination.
    – Trials arranged with exclusion criteria which make the vaccine appear to be less dangerous than it is in reality.
    – Lack of a true placebo in the trials, which also make the vaccine appear to be less dangerous than it is in reality.
    – Multi-dose formulation which necessitates an antimicrobial preservative, the choice being a toxic combination of m-cresol, phenol and benzyl alcohol.
    – Adjuvants, being in addition to neurotoxic aluminium (which is also an ingredient in Gardasil), a saponin, cholesterol, and a phospholipid.

    Saponins are irritants and potent immune stimulators. Their applicability as vaccine adjuvants is controversial due to associated toxicity.
    Phospholipids, cholesterol or any fatty substances when injected may cause the immune system to see them as invaders and increase risk of autoimmune disorders.

    There is serious reason to believe that this new vaccine may be even more dangerous than the predecessor Gardasil which already has permanently damaged the health of many thousands across the world and is the cause of countless deaths.

    Reply
  2. jimbo says

    February 15, 2017 at 8:56 am

    So the final case was due to be heard on 28th October 2014.
    What happened?
    I assume from the lack of hysteria that it was quashed?

    Reply
    • admin says

      February 16, 2017 at 3:34 am

      The ‘lack of hysteria’ as you put it comes from multiple postponements primarily resulting from last minute submissions by vaccine stakeholders. The case is still very much alive and pending final outcome.

      Reply

Trackbacks

  1. Supreme Court in India to Rule on Merck Fraud Regarding HPV Vaccine Deaths | Health Impact News says:
    July 8, 2014 at 4:01 pm

    […] Norma Erickson […]

    Reply
  2. Supreme Court in India to Rule on Merck Fraud Regarding HPV Vaccine Deaths | The Liberty Beacon says:
    July 10, 2014 at 12:40 pm

    […] Norma Erickson […]

    Reply
  3. AskYourGovernment » Blog Archive » Supreme Court in India to Rule on Merck Fraud Regarding HPV Vaccine Deaths says:
    July 14, 2014 at 6:40 am

    […] By Norma EricksonSanevax.org […]

    Reply
  4. winbango » Blog Archive » Supreme Court in India to Rule on Merck Fraud Regarding HPV Vaccine Deaths says:
    July 14, 2014 at 6:46 am

    […] By Norma EricksonSanevax.org […]

    Reply
  5. De nuevo graves acusaciones contra el fabricante de la vacuna del papiloma por sus ensayos en la India | Arsenal Terapéutico says:
    July 17, 2014 at 3:54 am

    […] nuevas y graves acusaciones contra Sanofi Pasteur Merck, Sharp & Dohme (MSD) en India por los ensayos clínicos que está haciendo de su nueva vacuna del papiloma denominada V503 que es […]

    Reply
  6. Asociación Afectados por Vacunas (AxV) says:
    July 21, 2014 at 3:28 pm

    […] nuevas y graves acusaciones contra Sanofi Pasteur Merck, Sharp & Dohme (MSD) en India por los ensayos clínicos que está haciendo de su nueva vacuna del papiloma denominada V503 que es […]

    Reply
  7. Will India be First Country to Revoke Marketing Licenses for HPV Vaccines? | Vaccine Impact says:
    November 20, 2014 at 5:29 pm

    […] https://sanevax.org/hpv-vaccine-trials-in-india-is-merck-above-the-law/ […]

    Reply
  8. Lieferte Merck & Co (MSD – Sharp & Dohme GmbH) illegal tonnenweise Euthanasiemittel für Hunde Beuthanasia D in die USA für Hinrichtungen? Hat die MSD in Beuthanasia D pures N, N-Dimethylformamide (DMF) hineingeschmuggelt? Die MSD vertreibt w says:
    December 28, 2018 at 6:47 pm

    […] https://sanevax.org/hpv-vaccine-trials-in-india-is-merck-above-the-law/ […]

    Reply
  9. Der Betrug Tierversuch – der Grund weswegen wir an Krebs erkranken: Eingeimpfte tierische Tumorviren SV 40 haben eine Krebsepidemie (Osteo-sarkome, Gehirntumore & Nicht-Hodgkin-Lymphome) ausgelöst, die sich bis heute auch unter den Ungeimpften says:
    December 28, 2018 at 11:20 pm

    […] HPV Vaccine Trials in India: Is Merck above the law? […]

    Reply
  10. Der Betrug Tierversuch – der Grund weswegen wir an Krebs erkranken: Eingeimpfte tierische Tumorviren SV 40 haben eine Krebsepidemie (Osteosarkome, Gehirntumore & Nicht-Hodgkin-Lymphome) ausgelöst, die sich bis heute auch unter den Ungeimpften says:
    December 29, 2018 at 12:16 am

    […] HPV Vaccine Trials in India: Is Merck above the law? […]

    Reply
  11. D و Intervet تمام جهان را تقلب می کند! T61 نمی کشد – آن را زنده، متوقف بیهوشی و فورا فلج – شواهد در حیوانات و انسان است. آیا شیطان در سراسر جهان م says:
    December 29, 2018 at 11:59 am

    […] https://sanevax.org/hpv-vaccine-trials-in-india-is-merck-above-the-law/ […]

    Reply
  12. MSD`s & Intervets Urkundenfälschung T61 & Stelzls (HS Immoteam UG) Urkundenfälschung wird von den Richtern im Landgericht München I & Staatsanwaltschaft München I gedeckt! Darf Großgastronom Karl Rieder betrügen & soll Menschen v says:
    April 19, 2019 at 10:38 am

    […] HPV Vaccine Trials in India: Is Merck above the law? […]

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Follow Us

SaneVax on FacebookSaneVax on TwitterSaneVax on LinkedInSaneVax on YoutubeSaneVax RSS Feed

Help Support SaneVax

Notice: We need your support. This massive research & presentation comes from a team of volunteers. We need your help to keep this critical information available.



SaneVax relies on support from participants like you. We are a 501 (c)(3) non-profit corporation, donations are tax deductible. Help keep this venue available and support the spirit – Thank you!

This Week’s Survivor

Gardasil: Hanging on to Hope

Categories

Links

  • Creating an HPV Industry
  • File a VAERS Report
  • Gardasil and Unexplained Deaths
  • HPV Industry Timeline
  • HPV Mechanisms of Action in Women
  • HPV Vaccine Fact Sheet
  • Petition: Rescind HPV Vaccine Approval
  • Presentation to the FDA
  • Supreme Court Arguments

HPV Vaccine VAERS Reports

Description 12/14/2019  TOTAL
Disabled 3,092
Deaths 523
Did Not Recover 13,072
Abnormal Smear 695
Cervical Cancer 186
Infertility 52
Life-threatening 1,001
Emergency Room 15,419
Hospitalized 6,448
Extended Hosp. Stay 304
Serious 9,497
Total Adverse Events 64,270

Access expanded report here.

Related

Subscribe2


 

Log In

Featured Video

hpv autoimmune disorder

HPV Vaccine Side Effect Causes Autoimmune Disorder

News

SaneVax News Blog!
News

Videos

Safety • Victims • Pharma
No Genetic Epidemic

Contact

Contact S.A.N.E.Vax
S.A.N.E.VAX log thumbnail

Copyright © 2025 SaneVax, Inc. · Site by TheWebElves.com a div. of KalaRhythms.org · Log in

 

Loading Comments...